These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6821487)

  • 21. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus].
    Pfützner A; Berger S; Spinas G
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morbidity and mortality of diabetic ketoacidosis with and without insulin pump care.
    Realsen J; Goettle H; Chase HP
    Diabetes Technol Ther; 2012 Dec; 14(12):1149-54. PubMed ID: 23009106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment Modality-Dependent Risk of Diabetic Ketoacidosis in Patients with Type 1 Diabetes: Danish Adult Diabetes Database Study.
    Hoshina S; Andersen GS; Jørgensen ME; Ridderstråle M; Vistisen D; Andersen HU
    Diabetes Technol Ther; 2018 Mar; 20(3):229-234. PubMed ID: 29437465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Metabolic consequences of a 6-hour interruption of a continuous subcutaneous insulin infusion pump in insulin-dependent diabetic patients].
    Scheen AJ
    Rev Med Liege; 1987 Nov; 42(21):837-52. PubMed ID: 2892242
    [No Abstract]   [Full Text] [Related]  

  • 25. Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study.
    Nimri R; Weintrob N; Benzaquen H; Ofan R; Fayman G; Phillip M
    Pediatrics; 2006 Jun; 117(6):2126-31. PubMed ID: 16740856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute complications associated with the use of insulin infusion pumps.
    Mecklenburg RS
    Diabetes Educ; 1989; 15(1):40-3. PubMed ID: 2491989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients.
    Razavi Z; Maher S; Fredmal J
    Endocrine; 2018 Aug; 61(2):267-274. PubMed ID: 29797212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous intravenous insulin infusion in the management of brittle diabetes: etiologic and therapeutic implications.
    Williams G; Pickup JC; Keen H
    Diabetes Care; 1985; 8(1):21-7. PubMed ID: 3971843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting insulin requirements for a portable insulin pump using the Biostator. Evidence for reversible insulin resistance in poorly controlled type I diabetics.
    Mayfield RK; Sullivan FM; Colwell JA; Wohltmann HJ
    Diabetes; 1983 Oct; 32(10):908-14. PubMed ID: 6352376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion].
    Szypowska A; Pańkowska E; Lipka M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
    Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
    Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous subcutaneous insulin infusion: Special needs for children.
    Adolfsson P; Ziegler R; Hanas R
    Pediatr Diabetes; 2017 Jun; 18(4):255-261. PubMed ID: 28425167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An observational 7-year study of continuous subcutaneous insulin infusion for the treatment of type 1 diabetes mellitus.
    Papargyri P; Ojeda Rodríguez S; Corrales Hernández JJ; Mories Álvarez MT; Recio Córdova JM; Delgado Gómez M; Sánchez Marcos AI; Iglesias López RA; Herrero Ruiz A; Beaulieu Oriol M; Miralles García JM
    Endocrinol Nutr; 2014 Mar; 61(3):141-6. PubMed ID: 24355548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful treatment of insulin allergy in a type 1 diabetic patient by means of constant subcutaneous pump infusion of insulin.
    Sola-Gazagnes A; Pecquet C; Radermecker R; Piétri L; Elgrably F; Slama G; Sélam JL
    Diabetes Care; 2003 Oct; 26(10):2961-2. PubMed ID: 14514615
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of resistance to subcutaneous insulin with implanted insulin infusion pumps].
    Löchli S; Campbell I; Dorenboos H; Paterson KR; Devlin JG; Hagmüller G; Irsigler K
    Dtsch Med Wochenschr; 1988 Sep; 113(36):1390-3. PubMed ID: 3138098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of insulin-dependent diabetes by continuous sub-cutaneous insulin perfusion].
    Berger M; Sonnenberg E; Chantelau EA; Best F
    Journ Annu Diabetol Hotel Dieu; 1984; ():175-82. PubMed ID: 6443218
    [No Abstract]   [Full Text] [Related]  

  • 37. Sudden death due to diabetic ketoacidosis following power failure of an insulin pump: Autopsy and pump data.
    Kjærulff MLBG; Astrup BS
    J Forensic Leg Med; 2019 Apr; 63():34-39. PubMed ID: 30856551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperkalaemia, ketoacidosis and subcutaneous or intravenous insulin infusions.
    MacRury SM; Small M; MacCuish AC
    Diabetes Res; 1987 Jul; 5(3):153-5. PubMed ID: 3117474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
    Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
    JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.